Search all trials

Find therapies in clinical trials near you – page 34

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

COVID-19

Not recruiting

Registered drugNo placebo

Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Nirmatrelvir

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Oesophageal carcinoma

Not recruiting

Registered drug

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Calcium Folinate

Contact Research Centre

Pneumonia bacterial

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cilastatin

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

France

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Not recruiting

Registered drug

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Prednisone

Contact Research Centre

Breast cancer metastatic

Not recruiting

Registered drugNo placebo

Study on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Alpelisib

Contact Research Centre

Prostate cancer recurrent

Not recruiting

Registered drug

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Hidradenitis

Not recruiting

Investigational

Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Investigational

France

Participants:18–64 years · 65+ years
Substances:Sar442970

Contact Research Centre

Giant cell arteritis

Not recruiting

Registered drugNo placebo

Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Tocilizumab

Contact Research Centre

Colon cancer

Not recruiting

Registered drugNo placebo

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Find therapies in clinical trials near you – page 34

417 trials match your criteria

COVID-19

Study on Antiviral Therapy with Nirmatrelvir and Remdesivir for Immunocompromised COVID-19 Patients

Hepatocellular carcinoma

Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

Oesophageal carcinoma

Study of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy

Pneumonia bacterial

Study on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia

Colitis ulcerative

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Neoplasm malignant

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Breast cancer metastatic

Study on Alpelisib and Fulvestrant or Ribociclib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer with PIK3CA Mutations

Prostate cancer recurrent

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Hidradenitis

Study on the Effects and Safety of SAR442970 for Adults with Moderate to Severe Hidradenitis Suppurativa

Giant cell arteritis

Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

Colon cancer

Comparison of drug combinations containing irinotecan, oxaliplatin, fluorouracil and folinic acid for treatment of high-risk stage III colon cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.